Skip Navigation
Menu
College News Notes |1 December 1951

THIRTY-THIRD ANNUAL SESSION: Cleveland, Ohio: April 21-25, 1952

FULL TEXT

This content is PDF only. Please click on the PDF icon to access.

Abstract

According to advance reports from President Maurice C. Pincoffs and General Chairman Roy W. Scott, great plans are about concluded for a superior program of Morning Symposia, General Sessions, Hospital Clinics, Color Televised Clinics and Clinico-Pathological Conferences for the forthcoming Annual Session of the College. All scientific sessions, with the exception of the Hospital Clinics, will be held in the Public Auditorium, where excellent facilities are available. Hospital Clinics will be held on Tuesday and Thursday mornings, terminating in time for physicians to return to the Auditorium for the Panel Discussions and Clinico-Pathological Conferences. There will be four concurrent Panel

FULL TEXT
PDF
Not Available
Citations
Citation

THIRTY-THIRD ANNUAL SESSION: Cleveland, Ohio: April 21-25, 1952. Ann Intern Med. 1951;35:1396–1425. doi: 10.7326/0003-4819-35-6-1396

Download citation file:

© 2019

×
Permissions

Published: Ann Intern Med. 1951;35(6):1396-1425.

DOI: 10.7326/0003-4819-35-6-1396

0 Citations

Related Articles
Kidney Damage Biomarkers and Incident Chronic Kidney Disease During Blood Pressure Reduction: A Case–Control Study
Annals of Internal Medicine; 169 (9): 610-618
The Emergence of Neisseria gonorrhoeae with Decreased Susceptibility to Ciprofloxacin in Cleveland, Ohio: Epidemiology and Risk Factors
Annals of Internal Medicine; 125 (6): 465-470
Call for Comments on a Proposal To Improve Reporting of Clinical Trials in the Biomedical Literature
Annals of Internal Medicine; 121 (11): 894-895
Nosocomial Legionnaires' Disease in Columbus, Ohio
Annals of Internal Medicine; 90 (4): 565-569
View MoreView Less

PubMed Articles
Triple versus Dual Inhaler therapy in moderate-to-severe COPD: A systematic review and meta-analysis of randomized controlled trials.
Clin Respir J 2019.
A Mixture of U.S. Food and Drug Administration-Approved Monoaminergic Drugs Protects the Retina From Light Damage in Diverse Models of Night Blindness.
Invest Ophthalmol Vis Sci 2019;60(5):1442-1453.
View More

Results provided by: PubMed

CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2019 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×